v3 Template
R

REGENXBIO Inc.

Biotechnology Rockville, MD, USA
Founded
--
Employees
--
Total Funding
$265.0M
Funding Rounds
2
Last Funding
2024-03-06

About REGENXBIO Inc.

REGENXBIO is a leading clinical-stage biotechnology company focused on improving lives through the curative potential of gene therapy. They are pioneering a new field of discovery with their NAV(r) Technology Platform, aiming to deliver one-time treatments for common and rare diseases.

Products & Services

NAV(r) Technology Platform:A proprietary platform for developing gene therapy product candidates in retinal, metabolic, and neurodegenerative therapeutic areas.
ABBV-RGX-314:A gene therapy candidate for retinal diseases.

Specialties

Gene Therapy AAV (Adeno-Associated Virus) Vectors Retinal Diseases Metabolic Diseases Neurodegenerative Diseases

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering 		A: 125000000
MR: -
FA: $125,000,000
FAN: 125000000 		D: 2024-03-06
FD: 2024-03-06 		4 investors
2 RT: Public Offering
T: -
FT: Public Offering 		A: 140000000
MR: -
FA: approximately $140.0 million
FAN: 140000000 		D: 2024-03-06
FD: 2024-03-06 		4 investors
Public Offering Latest
2024-03-06
$125.0M
4 investors (Pro only)
Public Offering 2024-03-06
$140.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

REGENXBIO Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Locations
Rockville, MD, USA
Rockville, Md.

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro